Paroxysmal nocturnal hemoglobinuria laboratory findings: Difference between revisions

	Paroxysmal nocturnal hemoglobinuria Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Paroxysmal nocturnal hemoglobinuria from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Paroxysmal nocturnal hemoglobinuria laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Paroxysmal nocturnal hemoglobinuria laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Paroxysmal nocturnal hemoglobinuria laboratory findings
CDC on Paroxysmal nocturnal hemoglobinuria laboratory findings
Paroxysmal nocturnal hemoglobinuria laboratory findings in the news
Blogs on Paroxysmal nocturnal hemoglobinuria laboratory findings
Directions to Hospitals Treating Paroxysmal nocturnal hemoglobinuria
Risk calculators and risk factors for Paroxysmal nocturnal hemoglobinuria laboratory findings

VisualWikitext

Revision as of 16:51, 2 July 2018

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].

OR

Laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].

OR

[Test] is usually normal for patients with [disease name].

OR

Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].

OR

There are no diagnostic laboratory findings associated with [disease name].

Laboratory Findings

There are no diagnostic laboratory findings associated with [disease name].

OR

An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].

OR

[Test] is usually normal among patients with [disease name].

OR

Laboratory findings consistent with the diagnosis of [disease name] include:

[Abnormal test 1]
[Abnormal test 2]
[Abnormal test 3]

OR

Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].

References

Template:WH Template:WS

@@ Line 1: / Line 1: @@
 __NOTOC__
-{{ Paroxysmal nocturnal hemoglobinuria }}
+{{Paroxysmal nocturnal hemoglobinuria}}
-{{CMG}}
+{{CMG}}; {{AE}}
 ==Overview==
+An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].
+OR
+Laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].
+OR
+[Test] is usually normal for patients with [disease name].
+OR
+Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].
+OR
+There are no diagnostic laboratory findings associated with [disease name].
 ==Laboratory Findings==
-* PNH can present with or as other disease entities such as aplastic anemia or myelodysplasia (MDS).  Patients who present with pancytopenia or thrombosis compounding anemia should be suspected of having PNH. Many patients with bone marrow failure ([[aplastic anemia]]) develop [[PNH]](10-33%). Aplastic anemia can be caused by an attack by the immune system against the bone marrow. For this reason, drugs that suppress the immune system are being researched as a therapy for PNH.<ref>Sacher, Ronald A. and Richard A. McPherson. "Wildman's Clinical Interpretation of Laboratory Tests, 11th edition."</ref> <ref>Kumar, Vinay, Abu Abbas, and Nelson Fausto. "Robbins and Cotran Pathologic Basis of Disease, 7th edition."</ref>  A small percentage of PNH patients can have dysplasia that leads to Acute Myelocytic Leukemia.  Interestingly, the blasts of the PNH-derived AML also lack leukocyte alkaline phosphatase (LAP) and decay accelerating factor (CD59;DAF).
-*'''Ham's acid hemolysis test''':  A sugar or sucrose lysis test, in which a patient's red blood cells are placed in low ionic strength solution and observed for hemolysis, is used for screening. A more specific test for PNH, called ''Ham's acid hemolysis'' test, is performed if the sugar test is positive for hemolysis.<ref>Ham TH. Chronic haemolytic anaemia with paroxysmal nocturnal haemoglobinuria: study of the mechanism of haemolysis in relation to acid-base equilibrium. ''[[N Engl J Med]]'' 1937;217:915-918.</ref>  In a positive sucrose lysis test ionic strength facilitates the complement binding whereas in a positive Ham acid hemolysis test acidic strength facilitates the complement binding.  The differential diagnosis of a positive sugar lysis test includes some autoimmune hemolytic anemias; even leukemias can give a false positive result.  The differential diagnosis for a positive Ham test includes congenital dyserythropoietic anemia; note that a negative Ham test doesn't rule out PNH.  These assays do not reliably quantitate the percentage of PNH cells and can be falsely negative in patients who have received red blood cell transfusions. Occasionally the characteristic complement-sensitive erythrocytes cannot be demonstrated in patients with well-established PNH. This probably occurs when the production of PNH cells is relatively low and most of the PNH cells that have been made have already been destroyed either in the marrow or in the circulation.  Therefore a single normal sucrose hemolysis test cannot be considered absolute evidence that a patient does not have PNH.
+There are no diagnostic laboratory findings associated with [disease name].
+OR
+An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].
+OR
+[Test] is usually normal among patients with [disease name].
+OR
+Laboratory findings consistent with the diagnosis of [disease name] include:
+*[Abnormal test 1]
+*[Abnormal test 2]
+*[Abnormal test 3]
+OR
+Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].
 ==References==
 {{Reflist|2}}
-[[Category:Hematology]]
-[[Category:Rheumatology]]
-[[Category:Mature chapter]]
 {{WH}}
 {{WS}}
+[[Category: (name of the system)]]

Paroxysmal nocturnal hemoglobinuria laboratory findings: Difference between revisions

Revision as of 16:51, 2 July 2018

Overview

Laboratory Findings

References

Navigation menu